An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
Clinical trial NCT02123966 · TERMINATED
Trial details
- NCT number
- NCT02123966
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-05-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.